Pérez-Mancera Pedro A, Bermejo-Rodríguez Camino, Sánchez-Martín Manuel, Abollo-Jiménez Fernando, Pintado Belén, Sánchez-García Isidro
Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/ Universidad de Salamanca, Salamanca, Spain.
PLoS One. 2008 Jul 2;3(7):e2569. doi: 10.1371/journal.pone.0002569.
FUS-DDIT3 is a chimeric protein generated by the most common chromosomal translocation t(12;16)(q13;p11) linked to liposarcomas, which are characterized by the accumulation of early adipocytic precursors. Current studies indicate that FUS-DDIT3- liposarcoma develops from uncommitted progenitors. However, the precise mechanism whereby FUS-DDIT3 contributes to the differentiation arrest remains to be elucidated.
METHODOLOGY/PRINCIPAL FINDINGS: Here we have characterized the adipocyte regulatory protein network in liposarcomas of FUS-DITT3 transgenic mice and showed that PPARgamma2 and C/EBPalpha expression was altered. Consistent with in vivo data, FUS-DDIT3 MEFs and human liposarcoma cell lines showed a similar downregulation of both PPARgamma2 and C/EBPalpha expression. Complementation studies with PPARgamma but not C/EBPalpha rescued the differentiation block in committed adipocytic precursors expressing FUS-DDIT3. Our results further show that FUS-DDIT3 interferes with the control of initiation of translation by upregulation of the eukaryotic translation initiation factors eIF2 and eIF4E both in FUS-DDIT3 mice and human liposarcomas cell lines, explaining the shift towards the truncated p30 isoform of C/EBPalpha in liposarcomas. Suppression of the FUS-DDIT3 transgene did rescue this adipocyte differentiation block. Moreover, eIF4E was also strongly upregulated in normal adipose tissue of FUS-DDIT3 transgenic mice, suggesting that overexpression of eIF4E may be a primary event in the initiation of liposarcomas. Reporter assays showed FUS-DDIT3 is involved in the upregulation of eIF4E in liposarcomas and that both domains of the fusion protein are required for affecting eIF4E expression.
CONCLUSIONS/SIGNIFICANCE: Taken together, this study provides evidence of the molecular mechanisms involve in the disruption of normal adipocyte differentiation program in liposarcoma harbouring the chimeric gene FUS-DDIT3.
FUS-DDIT3是一种嵌合蛋白,由与脂肪肉瘤相关的最常见染色体易位t(12;16)(q13;p11)产生,脂肪肉瘤的特征是早期脂肪细胞前体的积累。目前的研究表明,FUS-DDIT3脂肪肉瘤由未定向祖细胞发展而来。然而,FUS-DDIT3导致分化停滞的确切机制仍有待阐明。
方法/主要发现:在这里,我们对FUS-DITT3转基因小鼠脂肪肉瘤中的脂肪细胞调节蛋白网络进行了表征,并表明PPARγ2和C/EBPα的表达发生了改变。与体内数据一致,FUS-DDIT3小鼠胚胎成纤维细胞(MEFs)和人脂肪肉瘤细胞系显示出PPARγ2和C/EBPα表达的类似下调。用PPARγ而不是C/EBPα进行的互补研究挽救了表达FUS-DDIT3的定向脂肪细胞前体中的分化阻滞。我们的结果进一步表明,FUS-DDIT3通过上调真核翻译起始因子eIF2和eIF4E来干扰翻译起始的控制,这在FUS-DDIT3小鼠和人脂肪肉瘤细胞系中均有体现,解释了脂肪肉瘤中C/EBPα向截短的p30异构体的转变。FUS-DDIT3转基因的抑制确实挽救了这种脂肪细胞分化阻滞。此外,eIF4E在FUS-DDIT3转基因小鼠的正常脂肪组织中也强烈上调,表明eIF4E的过表达可能是脂肪肉瘤发生的主要事件。报告基因分析表明,FUS-DDIT3参与脂肪肉瘤中eIF4E的上调,并且融合蛋白的两个结构域对于影响eIF4E表达都是必需的。
结论/意义:综上所述,本研究提供了分子机制的证据,该机制涉及携带嵌合基因FUS-DDIT3的脂肪肉瘤中正常脂肪细胞分化程序的破坏。